Replies to post #59363 on Biotech Values

[palindromy]

They had about 60m debt based on royalty financing of a marketed drug(argatroban) and 120m or so issued in convertibles when their stock was much higher.

If only more biotechs had borrowed money when bankers were throwing them around.. oh wait they couldnt just submit a stated income form.